EPISODE · Nov 16, 2024 · 14 MIN
Ad Promo Review in Pharma - How Far is Too Far?
from DarshanTalks Podcast · host Darshan Kulkarni
Send us Fan MailKatie Graham and I discuss various aspects of FDA and FTC regulations, including ad promo, the Chevron decision, and the evolving role of compliance in the pharmaceutical industry.Key topics include:What is Ad Promo?Chevron decision's influence on FDA/FTCShould administrative agencies cite letters? Can the FDA establish rules after someone challenges them?Uncertainty of Compliance White SpaceIs regulatory medical advice now just seen as a risk?Support the showwww.kulkarnilawfirm.com
Embed this episode
NOW PLAYING
Ad Promo Review in Pharma - How Far is Too Far?
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.